

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the Ameri...


(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnolog...


UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price


Scancell Rises On Launch Of Covid-19 Vaccine Research Programme


UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost


(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United State...


Scancell Gets US FDA Approval For SCIB1 Drug Application


Scancell Interim Loss Narrows, Progresses On Product Pipeline